Tectonic Therapeutic plans to launch a Phase 2 clinical trial to test the impact of its therapy candidate TX45 on blood flow, or hemodynamics, in people with pulmonary hypertension and interstitial lung disease (PH-ILD). The move comes on the heels of positive results from part A of a Phase 1b clinical trial, which showed that […] The post Tectonic planning trial to test TX45 impact on blood flow in PH-ILD appeared first on Pulmonary Hypertension News.
